| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.3109/00207458808991596 |
| P698 | PubMed publication ID | 3061953 |
| P2093 | author name string | Sandyk R | |
| Fisher H | |||
| P2860 | cites work | Biochemical investigations in patients with Parkinson's disease treated with L-dopa | Q51108402 |
| Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor | Q51116310 | ||
| L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition. | Q51147907 | ||
| The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum. | Q51185764 | ||
| 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome. | Q51211033 | ||
| The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. | Q51328427 | ||
| Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. | Q52078151 | ||
| Depression, intellectual impairment, and Parkinson disease. | Q52101557 | ||
| Gilles de la Tourette syndrome: clinical and family study of 50 cases. | Q52300495 | ||
| Chronic parkinsonism secondary to intravenous injection of meperidine analogues | Q28323857 | ||
| L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients | Q28332572 | ||
| Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients | Q28337175 | ||
| Alterations of brain neurotransmitter receptor binding in Huntington's chorea | Q31152135 | ||
| Radioautographic study of in vivo incorporation of 3H-monoamines in the cat caudate nucleus: identification of serotoninergic fibers | Q31925343 | ||
| Endogenous pain control mechanisms: Review and hypothesis | Q34188796 | ||
| An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat | Q34237223 | ||
| PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA. | Q34256347 | ||
| [3H]Mesulergine, a selective ligand for serotonin-2 receptors | Q34271841 | ||
| Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. | Q36450559 | ||
| A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q37343442 | ||
| The serotonergic system in the brain and its possible functional connections with other aminergic systems | Q39064963 | ||
| Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways | Q39096616 | ||
| Circling behaviour produced by asymmetric medial raphe nuclei lesions in rats | Q39099103 | ||
| Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study | Q39490606 | ||
| Serotonin neurons of the midbrain raphe: ascending projections | Q39491709 | ||
| Effect of drugs influencing central serotonergic mechanisms on methamphetamine-induced stereotyped behavior in the rat | Q39696292 | ||
| Differential effects of serotonin on turning and stereotypy induced by apomorphine | Q39735793 | ||
| Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice | Q39761971 | ||
| Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones | Q39803397 | ||
| A quantitative rotational model for studying serotonergic function in the rat | Q39806587 | ||
| Interaction in the cerebral metabolism of the biogenic amines: Effect of intravenous infusion of l‐tryptophan on the metabolism of dopamine and 5‐hydroxyindoles in brain and cerebrospinal fluid | Q39985471 | ||
| The physiology and pharmacology of mammalian basal ganglia | Q40082826 | ||
| Neurotransmitter receptor alterations in Parkinson's disease | Q40093350 | ||
| Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors | Q40130681 | ||
| Decreased serotoninergic activity in Tourette syndrome | Q40608442 | ||
| Purine Phosphoribosyltransferase in Gilles de la Tourette Syndrome | Q40640349 | ||
| Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine | Q48710018 | ||
| Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: Correlations with serotonin levels and histochemical fluorescence | Q48727187 | ||
| Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease | Q48737270 | ||
| Release of transmitters on stimulation of the nucleus linearis raphe in the cat | Q48766976 | ||
| A case of Gilles de la Tourette's syndrome treated with clonazepam | Q48768692 | ||
| Regional distribution of monoamines in the corpus striatum of the rat | Q48786995 | ||
| L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice | Q48918393 | ||
| Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders | Q48921302 | ||
| Depressed Monoamine Catabolite Levels in Cerebrospinal Fluid of Patients with Parkinsonism Dementia of Guam | Q48922777 | ||
| Disorders of arousal in Gilles de la Tourette's syndrome | Q49075458 | ||
| Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome | Q49078848 | ||
| Sleep in Gilles de la Tourette's syndrome: disorder of arousal | Q49113052 | ||
| The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations | Q49134712 | ||
| Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents | Q49145577 | ||
| Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: Co-operative interactions of serotonin and dopamine in neostriatum | Q40729820 | ||
| Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa | Q41220570 | ||
| The endogenous opioid system in Gilles de la Tourette syndrome | Q41341918 | ||
| Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam | Q41347235 | ||
| L-Dopa-Induced Release of Cerebral Monoamines | Q41522173 | ||
| Increased serotonin turnover in corpus striatum following an injection of kainic acid: Evidence for neuronal feedback regulation of synthesis | Q41645146 | ||
| Transmitter-specific retrograde labeling in the striato-nigral and raphe-nigral pathways | Q41653103 | ||
| Tetanus toxin and synaptic inhibition in the substantia nigra and striatum of the rat | Q41744233 | ||
| L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent | Q41763408 | ||
| Treatment of phenothiazine-induced dyskinesia | Q41983693 | ||
| The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. | Q42219627 | ||
| Possible development of the serotonin syndrome in man. | Q42264102 | ||
| Dopamine receptor blockade--a central action of chlorpromazine on striatal neurones. | Q42439044 | ||
| Behavioral effects of selective midbrain raphe lesions in the rat | Q42597460 | ||
| Rapid deterioration in patients with parkinsonism following tryptophan-pyridoxine administration | Q43647905 | ||
| Treatment of progressive supranuclear palsy with tricyclic antidepressants | Q43793659 | ||
| Primary sensory symptoms in parkinsonism | Q44017121 | ||
| Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches | Q44022902 | ||
| Release of 5-hydroxytryptamine from caudate nucleus and septum | Q44533281 | ||
| The nucleus linearis intermedius raphe and behaviour evoked by direct and indirect stimulation of dopamine-sensitive sites within the caudate nucleus of cats | Q44587256 | ||
| The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brain | Q44842773 | ||
| Normalization of brain serotonin by L-tryptophan in levodopa-treated rats | Q45025589 | ||
| Clinical and biochemical features of depression in Parkinson's disease | Q45195312 | ||
| 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases | Q45303241 | ||
| 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus | Q46767973 | ||
| A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy | Q48160624 | ||
| The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations | Q48168348 | ||
| Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral gabaergic fibres | Q48202888 | ||
| Increase in large neutral amino acid transport into brain by insulin | Q48231236 | ||
| Convergence of excitatory synaptic inputs to caudate spiny neurons | Q48302152 | ||
| Daily variations of various parameters of serotonin metabolism in the rat brain. I. Circadian variations of tryptophan-5-hydroxylase in the raphe nuclei and the striatum | Q48307448 | ||
| The response of striatal cells upon stimulation of the dorsal and median raphe nuclei | Q48313569 | ||
| The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique | Q48344512 | ||
| Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
| Effects of alpha-flupenthixol on dopamine and 5-hydroxytryptamine responses of substantia nigra neurones | Q48346176 | ||
| The raphe nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography | Q48364298 | ||
| Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat. | Q48374727 | ||
| Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase — Interaction of d-LSD with dopaminergic receptors | Q48387933 | ||
| Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. I. Microestimation of [3H]dopamine uptake and dopamine content in microdiscs | Q48387940 | ||
| Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine afferents | Q48394019 | ||
| Tryptophan hydroxylase: Activation invitro following stimulation of central serotonergic neurons | Q48433517 | ||
| Anatomical and electrophysiological identification of a projection from the mesencephalic raphe to the caudate-putamen in the rat | Q48434958 | ||
| Regulation of 5-hydroxytryptamine metabolism in mouse brain by adrenal glucocorticoids | Q48449593 | ||
| Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum | Q48454593 | ||
| Serotonin content of the brain stem nuclei in the rat. | Q48506055 | ||
| Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats | Q48513450 | ||
| Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat. | Q48521363 | ||
| Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study | Q48544904 | ||
| Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse | Q48567967 | ||
| MPTP alters central catecholamine neurons in addition to the nigrostriatal system | Q48597136 | ||
| Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms | Q48605771 | ||
| Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces dopamine and serotonin but accelerates norepinephrine metabolism in the rat brain. Effect of chronic pretreatment with MPTP | Q48668797 | ||
| The role of monoamines in rotation induced or potentiated by amphetamine after nigral, raphe and mesencephalic reticular lesions in the rat brain | Q48679287 | ||
| Altered serotonin metabolism in depressed patients with parkinson's disease | Q48680548 | ||
| Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat | Q48682433 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 185-208 | |
| P577 | publication date | 1988-10-01 | |
| P1433 | published in | International Journal of Neuroscience | Q6051511 |
| P1476 | title | Serotonin in involuntary movement disorders | |
| P478 | volume | 42 |
| Q48831449 | A drug naive parkinsonian patient successfully treated with weak electromagnetic fields |
| Q31440186 | Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study |
| Q52037873 | Biological determinants and risk factors for tardive dyskinesia in schizophrenia. |
| Q48950838 | Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine |
| Q42518175 | Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons |
| Q36118481 | Dystrophic serotonergic axons in neurodegenerative diseases. |
| Q48319536 | Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. |
| Q35223132 | L-Tryptophan in Neuropsychiatry Disorders: A Review |
| Q38749646 | Locus coeruleus-pineal melatonin interactions and the pathogenesis of the "on-off" phenomenon associated with mood changes and sensory symptoms in Parkinson's disease |
| Q28334481 | MIF-induced augmentation of melatonin functions: possible relevance to mechanisms of action of MIF-1 in movement disorders |
| Q72452110 | Marked regional disturbances in brain metabolism of monoaminergic neurotransmitters in the genetically dystonic hamster |
| Q38018551 | Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin |
| Q41216098 | Pineal melatonin functions and the depression of Parkinson's disease: a hypothesis |
| Q48228497 | Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats |
| Q28332518 | Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient |
| Q37075326 | Relevance of the Habenular Complex to Neuropsychiatry: A Review and Hypothesis |
| Q51997893 | Reversal of cognitive impairment in an elderly parkinsonian patient by transcranial application of picotesla electromagnetic fields. |
| Q39792829 | Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors |
| Q48095383 | Reversal of micrographia in Parkinson's disease by application of picoTesla range magnetic fields |
| Q42456831 | Selective increases in serotonin 5-HT1B/1D and 5-HT2A/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons. |
| Q37226165 | Serotonin excites fast-spiking interneurons in the striatum |
| Q44741106 | Serotonin fibre densities in subcortical areas: differential effects of isolated rearing and methamphetamine |
| Q41178359 | The relationship of negative schizophrenia to parkinsonism |
| Q35281449 | The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome |
Search more.